nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP2C8—Fenofibrate—coronary artery disease	0.0306	0.0453	CbGbCtD
Triazolam—CYP3A7—Eplerenone—coronary artery disease	0.0274	0.0405	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0274	0.0405	CbGbCtD
Triazolam—CYP2C8—Gemfibrozil—coronary artery disease	0.0245	0.0362	CbGbCtD
Triazolam—CYP3A5—Clopidogrel—coronary artery disease	0.0221	0.0327	CbGbCtD
Triazolam—CYP2C9—Fenofibrate—coronary artery disease	0.0214	0.0316	CbGbCtD
Triazolam—CYP2C8—Clopidogrel—coronary artery disease	0.0212	0.0314	CbGbCtD
Triazolam—CYP3A5—Eplerenone—coronary artery disease	0.0205	0.0304	CbGbCtD
Triazolam—CYP2C8—Pitavastatin—coronary artery disease	0.0186	0.0274	CbGbCtD
Triazolam—CYP3A7—Simvastatin—coronary artery disease	0.0176	0.0261	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.0176	0.0261	CbGbCtD
Triazolam—CYP3A7—Lovastatin—coronary artery disease	0.0173	0.0255	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.0173	0.0255	CbGbCtD
Triazolam—CYP2C9—Gemfibrozil—coronary artery disease	0.0171	0.0253	CbGbCtD
Triazolam—CYP3A7—Atorvastatin—coronary artery disease	0.0157	0.0232	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.0157	0.0232	CbGbCtD
Triazolam—CYP2C9—Clopidogrel—coronary artery disease	0.0148	0.0219	CbGbCtD
Triazolam—CYP3A5—Rosuvastatin—coronary artery disease	0.0142	0.021	CbGbCtD
Triazolam—CYP3A4—Ticagrelor—coronary artery disease	0.0139	0.0206	CbGbCtD
Triazolam—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.0133	0.0197	CbGbCtD
Triazolam—CYP3A5—Simvastatin—coronary artery disease	0.0132	0.0196	CbGbCtD
Triazolam—CYP3A5—Pravastatin—coronary artery disease	0.013	0.0191	CbGbCtD
Triazolam—CYP3A5—Lovastatin—coronary artery disease	0.013	0.0191	CbGbCtD
Triazolam—CYP2C9—Pitavastatin—coronary artery disease	0.0129	0.0191	CbGbCtD
Triazolam—CYP2C8—Simvastatin—coronary artery disease	0.0127	0.0188	CbGbCtD
Triazolam—CYP2C9—Valsartan—coronary artery disease	0.0126	0.0186	CbGbCtD
Triazolam—CYP2C8—Pravastatin—coronary artery disease	0.0125	0.0184	CbGbCtD
Triazolam—CYP2C8—Lovastatin—coronary artery disease	0.0125	0.0184	CbGbCtD
Triazolam—CYP3A4—Fenofibrate—coronary artery disease	0.0124	0.0184	CbGbCtD
Triazolam—CYP3A5—Atorvastatin—coronary artery disease	0.0118	0.0174	CbGbCtD
Triazolam—CYP2C8—Atorvastatin—coronary artery disease	0.0113	0.0168	CbGbCtD
Triazolam—CYP3A5—Losartan—coronary artery disease	0.0108	0.0159	CbGbCtD
Triazolam—CYP2C8—Losartan—coronary artery disease	0.0104	0.0153	CbGbCtD
Triazolam—CYP3A4—Gemfibrozil—coronary artery disease	0.00994	0.0147	CbGbCtD
Triazolam—CYP2C9—Rosuvastatin—coronary artery disease	0.00955	0.0141	CbGbCtD
Triazolam—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0093	0.0138	CbGbCtD
Triazolam—CYP2C9—Simvastatin—coronary artery disease	0.00888	0.0131	CbGbCtD
Triazolam—CYP2C9—Pravastatin—coronary artery disease	0.00869	0.0128	CbGbCtD
Triazolam—CYP2C9—Lovastatin—coronary artery disease	0.00869	0.0128	CbGbCtD
Triazolam—CYP3A4—Clopidogrel—coronary artery disease	0.00861	0.0127	CbGbCtD
Triazolam—CYP3A4—Eplerenone—coronary artery disease	0.00801	0.0118	CbGbCtD
Triazolam—CYP2C9—Atorvastatin—coronary artery disease	0.00791	0.0117	CbGbCtD
Triazolam—CYP2C9—Losartan—coronary artery disease	0.00723	0.0107	CbGbCtD
Triazolam—CYP3A4—Enalapril—coronary artery disease	0.00714	0.0106	CbGbCtD
Triazolam—CYP3A4—Rosuvastatin—coronary artery disease	0.00555	0.0082	CbGbCtD
Triazolam—CYP3A4—Ezetimibe—coronary artery disease	0.00555	0.0082	CbGbCtD
Triazolam—CYP3A4—Simvastatin—coronary artery disease	0.00516	0.00763	CbGbCtD
Triazolam—CYP3A4—Lovastatin—coronary artery disease	0.00505	0.00746	CbGbCtD
Triazolam—CYP3A4—Pravastatin—coronary artery disease	0.00505	0.00746	CbGbCtD
Triazolam—CYP3A4—Atorvastatin—coronary artery disease	0.0046	0.0068	CbGbCtD
Triazolam—CYP3A4—Losartan—coronary artery disease	0.00421	0.00622	CbGbCtD
Triazolam—Muscle spasms—Lisinopril—coronary artery disease	0.000142	0.000618	CcSEcCtD
Triazolam—Constipation—Perindopril—coronary artery disease	0.000141	0.000615	CcSEcCtD
Triazolam—Pain—Perindopril—coronary artery disease	0.000141	0.000615	CcSEcCtD
Triazolam—Vomiting—Fenofibrate—coronary artery disease	0.000141	0.000615	CcSEcCtD
Triazolam—Hypersensitivity—Valsartan—coronary artery disease	0.000141	0.000614	CcSEcCtD
Triazolam—Abdominal pain—Trandolapril—coronary artery disease	0.000141	0.000613	CcSEcCtD
Triazolam—Dizziness—Ezetimibe—coronary artery disease	0.00014	0.000612	CcSEcCtD
Triazolam—Palpitations—Timolol—coronary artery disease	0.00014	0.000612	CcSEcCtD
Triazolam—Abdominal pain—Enalapril—coronary artery disease	0.00014	0.00061	CcSEcCtD
Triazolam—Feeling abnormal—Captopril—coronary artery disease	0.00014	0.00061	CcSEcCtD
Triazolam—Insomnia—Losartan—coronary artery disease	0.00014	0.00061	CcSEcCtD
Triazolam—Dermatitis—Fenofibrate—coronary artery disease	0.00014	0.000609	CcSEcCtD
Triazolam—Loss of consciousness—Timolol—coronary artery disease	0.00014	0.000609	CcSEcCtD
Triazolam—Decreased appetite—Furosemide—coronary artery disease	0.000139	0.000608	CcSEcCtD
Triazolam—Headache—Fenofibrate—coronary artery disease	0.000139	0.000606	CcSEcCtD
Triazolam—Paraesthesia—Losartan—coronary artery disease	0.000139	0.000606	CcSEcCtD
Triazolam—Gastrointestinal pain—Captopril—coronary artery disease	0.000139	0.000606	CcSEcCtD
Triazolam—Vomiting—Clopidogrel—coronary artery disease	0.000139	0.000604	CcSEcCtD
Triazolam—Diarrhoea—Simvastatin—coronary artery disease	0.000139	0.000604	CcSEcCtD
Triazolam—Chest pain—Ramipril—coronary artery disease	0.000138	0.000603	CcSEcCtD
Triazolam—Fatigue—Furosemide—coronary artery disease	0.000138	0.000603	CcSEcCtD
Triazolam—Tremor—Lisinopril—coronary artery disease	0.000138	0.000602	CcSEcCtD
Triazolam—Abdominal pain—Telmisartan—coronary artery disease	0.000138	0.000602	CcSEcCtD
Triazolam—Dyspnoea—Losartan—coronary artery disease	0.000138	0.000601	CcSEcCtD
Triazolam—Anxiety—Ramipril—coronary artery disease	0.000138	0.000601	CcSEcCtD
Triazolam—Vomiting—Lovastatin—coronary artery disease	0.000138	0.0006	CcSEcCtD
Triazolam—Somnolence—Losartan—coronary artery disease	0.000138	0.0006	CcSEcCtD
Triazolam—Dizziness—Eplerenone—coronary artery disease	0.000137	0.000599	CcSEcCtD
Triazolam—Dermatitis—Clopidogrel—coronary artery disease	0.000137	0.000599	CcSEcCtD
Triazolam—Asthenia—Valsartan—coronary artery disease	0.000137	0.000598	CcSEcCtD
Triazolam—Hypertension—Timolol—coronary artery disease	0.000137	0.000598	CcSEcCtD
Triazolam—Constipation—Furosemide—coronary artery disease	0.000137	0.000598	CcSEcCtD
Triazolam—Pain—Furosemide—coronary artery disease	0.000137	0.000598	CcSEcCtD
Triazolam—Hypersensitivity—Niacin—coronary artery disease	0.000137	0.000597	CcSEcCtD
Triazolam—Ill-defined disorder—Lisinopril—coronary artery disease	0.000137	0.000596	CcSEcCtD
Triazolam—Discomfort—Ramipril—coronary artery disease	0.000137	0.000596	CcSEcCtD
Triazolam—Asthenia—Olmesartan—coronary artery disease	0.000137	0.000595	CcSEcCtD
Triazolam—Headache—Clopidogrel—coronary artery disease	0.000137	0.000595	CcSEcCtD
Triazolam—Dermatitis—Lovastatin—coronary artery disease	0.000136	0.000595	CcSEcCtD
Triazolam—Feeling abnormal—Perindopril—coronary artery disease	0.000136	0.000593	CcSEcCtD
Triazolam—Headache—Lovastatin—coronary artery disease	0.000136	0.000591	CcSEcCtD
Triazolam—Pruritus—Valsartan—coronary artery disease	0.000135	0.00059	CcSEcCtD
Triazolam—Dry mouth—Ramipril—coronary artery disease	0.000135	0.00059	CcSEcCtD
Triazolam—Chest pain—Timolol—coronary artery disease	0.000135	0.00059	CcSEcCtD
Triazolam—Vomiting—Ezetimibe—coronary artery disease	0.000135	0.000589	CcSEcCtD
Triazolam—Hypersensitivity—Pravastatin—coronary artery disease	0.000135	0.000588	CcSEcCtD
Triazolam—Gastrointestinal pain—Perindopril—coronary artery disease	0.000135	0.000588	CcSEcCtD
Triazolam—Anxiety—Timolol—coronary artery disease	0.000135	0.000588	CcSEcCtD
Triazolam—Pruritus—Olmesartan—coronary artery disease	0.000135	0.000587	CcSEcCtD
Triazolam—Decreased appetite—Losartan—coronary artery disease	0.000135	0.000586	CcSEcCtD
Triazolam—Abdominal pain—Captopril—coronary artery disease	0.000134	0.000585	CcSEcCtD
Triazolam—Dizziness—Simvastatin—coronary artery disease	0.000134	0.000584	CcSEcCtD
Triazolam—Dermatitis—Ezetimibe—coronary artery disease	0.000134	0.000583	CcSEcCtD
Triazolam—Confusional state—Ramipril—coronary artery disease	0.000134	0.000583	CcSEcCtD
Triazolam—Discomfort—Timolol—coronary artery disease	0.000134	0.000583	CcSEcCtD
Triazolam—Asthenia—Niacin—coronary artery disease	0.000133	0.000582	CcSEcCtD
Triazolam—Fatigue—Losartan—coronary artery disease	0.000133	0.000582	CcSEcCtD
Triazolam—Headache—Ezetimibe—coronary artery disease	0.000133	0.00058	CcSEcCtD
Triazolam—Malaise—Lisinopril—coronary artery disease	0.000133	0.00058	CcSEcCtD
Triazolam—Oedema—Ramipril—coronary artery disease	0.000133	0.000578	CcSEcCtD
Triazolam—Dry mouth—Timolol—coronary artery disease	0.000132	0.000577	CcSEcCtD
Triazolam—Pain—Losartan—coronary artery disease	0.000132	0.000577	CcSEcCtD
Triazolam—Constipation—Losartan—coronary artery disease	0.000132	0.000577	CcSEcCtD
Triazolam—Syncope—Lisinopril—coronary artery disease	0.000132	0.000576	CcSEcCtD
Triazolam—Vomiting—Eplerenone—coronary artery disease	0.000132	0.000576	CcSEcCtD
Triazolam—Feeling abnormal—Furosemide—coronary artery disease	0.000132	0.000576	CcSEcCtD
Triazolam—Nausea—Fenofibrate—coronary artery disease	0.000132	0.000574	CcSEcCtD
Triazolam—Pruritus—Niacin—coronary artery disease	0.000132	0.000574	CcSEcCtD
Triazolam—Asthenia—Pravastatin—coronary artery disease	0.000131	0.000573	CcSEcCtD
Triazolam—Gastrointestinal pain—Furosemide—coronary artery disease	0.000131	0.000572	CcSEcCtD
Triazolam—Hypersensitivity—Trandolapril—coronary artery disease	0.000131	0.000571	CcSEcCtD
Triazolam—Dermatitis—Eplerenone—coronary artery disease	0.000131	0.000571	CcSEcCtD
Triazolam—Diarrhoea—Valsartan—coronary artery disease	0.000131	0.000571	CcSEcCtD
Triazolam—Confusional state—Timolol—coronary artery disease	0.000131	0.00057	CcSEcCtD
Triazolam—Shock—Ramipril—coronary artery disease	0.000131	0.000569	CcSEcCtD
Triazolam—Hypersensitivity—Enalapril—coronary artery disease	0.000131	0.000569	CcSEcCtD
Triazolam—Abdominal pain—Perindopril—coronary artery disease	0.00013	0.000568	CcSEcCtD
Triazolam—Palpitations—Lisinopril—coronary artery disease	0.00013	0.000568	CcSEcCtD
Triazolam—Diarrhoea—Olmesartan—coronary artery disease	0.00013	0.000568	CcSEcCtD
Triazolam—Headache—Eplerenone—coronary artery disease	0.00013	0.000568	CcSEcCtD
Triazolam—Oedema—Timolol—coronary artery disease	0.00013	0.000565	CcSEcCtD
Triazolam—Pruritus—Pravastatin—coronary artery disease	0.00013	0.000565	CcSEcCtD
Triazolam—Loss of consciousness—Lisinopril—coronary artery disease	0.00013	0.000565	CcSEcCtD
Triazolam—Nausea—Clopidogrel—coronary artery disease	0.00013	0.000565	CcSEcCtD
Triazolam—Tachycardia—Ramipril—coronary artery disease	0.000129	0.000564	CcSEcCtD
Triazolam—Vomiting—Simvastatin—coronary artery disease	0.000129	0.000561	CcSEcCtD
Triazolam—Hypersensitivity—Telmisartan—coronary artery disease	0.000129	0.000561	CcSEcCtD
Triazolam—Nausea—Lovastatin—coronary artery disease	0.000129	0.000561	CcSEcCtD
Triazolam—Hyperhidrosis—Ramipril—coronary artery disease	0.000128	0.000559	CcSEcCtD
Triazolam—Dermatitis—Simvastatin—coronary artery disease	0.000128	0.000556	CcSEcCtD
Triazolam—Asthenia—Trandolapril—coronary artery disease	0.000128	0.000556	CcSEcCtD
Triazolam—Shock—Timolol—coronary artery disease	0.000128	0.000556	CcSEcCtD
Triazolam—Feeling abnormal—Losartan—coronary artery disease	0.000128	0.000556	CcSEcCtD
Triazolam—Diarrhoea—Niacin—coronary artery disease	0.000127	0.000555	CcSEcCtD
Triazolam—Asthenia—Enalapril—coronary artery disease	0.000127	0.000554	CcSEcCtD
Triazolam—Headache—Simvastatin—coronary artery disease	0.000127	0.000553	CcSEcCtD
Triazolam—Abdominal pain—Furosemide—coronary artery disease	0.000127	0.000553	CcSEcCtD
Triazolam—Gastrointestinal pain—Losartan—coronary artery disease	0.000127	0.000552	CcSEcCtD
Triazolam—Dizziness—Valsartan—coronary artery disease	0.000127	0.000551	CcSEcCtD
Triazolam—Anorexia—Ramipril—coronary artery disease	0.000126	0.000551	CcSEcCtD
Triazolam—Nausea—Ezetimibe—coronary artery disease	0.000126	0.00055	CcSEcCtD
Triazolam—Dizziness—Olmesartan—coronary artery disease	0.000126	0.000549	CcSEcCtD
Triazolam—Pruritus—Trandolapril—coronary artery disease	0.000126	0.000549	CcSEcCtD
Triazolam—Chest pain—Lisinopril—coronary artery disease	0.000126	0.000547	CcSEcCtD
Triazolam—Hyperhidrosis—Timolol—coronary artery disease	0.000125	0.000547	CcSEcCtD
Triazolam—Asthenia—Telmisartan—coronary artery disease	0.000125	0.000546	CcSEcCtD
Triazolam—Pruritus—Enalapril—coronary artery disease	0.000125	0.000546	CcSEcCtD
Triazolam—Diarrhoea—Pravastatin—coronary artery disease	0.000125	0.000546	CcSEcCtD
Triazolam—Anxiety—Lisinopril—coronary artery disease	0.000125	0.000545	CcSEcCtD
Triazolam—Discomfort—Lisinopril—coronary artery disease	0.000124	0.000541	CcSEcCtD
Triazolam—Anorexia—Timolol—coronary artery disease	0.000124	0.000539	CcSEcCtD
Triazolam—Pruritus—Telmisartan—coronary artery disease	0.000124	0.000539	CcSEcCtD
Triazolam—Nausea—Eplerenone—coronary artery disease	0.000123	0.000538	CcSEcCtD
Triazolam—Dizziness—Niacin—coronary artery disease	0.000123	0.000536	CcSEcCtD
Triazolam—Dry mouth—Lisinopril—coronary artery disease	0.000123	0.000535	CcSEcCtD
Triazolam—Abdominal pain—Losartan—coronary artery disease	0.000122	0.000533	CcSEcCtD
Triazolam—Asthenia—Captopril—coronary artery disease	0.000122	0.000531	CcSEcCtD
Triazolam—Diarrhoea—Trandolapril—coronary artery disease	0.000122	0.00053	CcSEcCtD
Triazolam—Vomiting—Valsartan—coronary artery disease	0.000122	0.00053	CcSEcCtD
Triazolam—Confusional state—Lisinopril—coronary artery disease	0.000121	0.000529	CcSEcCtD
Triazolam—Diarrhoea—Enalapril—coronary artery disease	0.000121	0.000528	CcSEcCtD
Triazolam—Dizziness—Pravastatin—coronary artery disease	0.000121	0.000528	CcSEcCtD
Triazolam—Vomiting—Olmesartan—coronary artery disease	0.000121	0.000528	CcSEcCtD
Triazolam—Dermatitis—Valsartan—coronary artery disease	0.000121	0.000525	CcSEcCtD
Triazolam—Nausea—Simvastatin—coronary artery disease	0.00012	0.000525	CcSEcCtD
Triazolam—Oedema—Lisinopril—coronary artery disease	0.00012	0.000525	CcSEcCtD
Triazolam—Pruritus—Captopril—coronary artery disease	0.00012	0.000524	CcSEcCtD
Triazolam—Insomnia—Ramipril—coronary artery disease	0.00012	0.000523	CcSEcCtD
Triazolam—Dermatitis—Olmesartan—coronary artery disease	0.00012	0.000523	CcSEcCtD
Triazolam—Headache—Valsartan—coronary artery disease	0.00012	0.000522	CcSEcCtD
Triazolam—Diarrhoea—Telmisartan—coronary artery disease	0.00012	0.000521	CcSEcCtD
Triazolam—Headache—Olmesartan—coronary artery disease	0.000119	0.00052	CcSEcCtD
Triazolam—Paraesthesia—Ramipril—coronary artery disease	0.000119	0.000519	CcSEcCtD
Triazolam—Shock—Lisinopril—coronary artery disease	0.000118	0.000516	CcSEcCtD
Triazolam—Asthenia—Perindopril—coronary artery disease	0.000118	0.000516	CcSEcCtD
Triazolam—Dyspnoea—Ramipril—coronary artery disease	0.000118	0.000516	CcSEcCtD
Triazolam—Vomiting—Niacin—coronary artery disease	0.000118	0.000516	CcSEcCtD
Triazolam—Hypersensitivity—Furosemide—coronary artery disease	0.000118	0.000515	CcSEcCtD
Triazolam—Somnolence—Ramipril—coronary artery disease	0.000118	0.000514	CcSEcCtD
Triazolam—Dizziness—Trandolapril—coronary artery disease	0.000118	0.000513	CcSEcCtD
Triazolam—Tachycardia—Lisinopril—coronary artery disease	0.000117	0.000512	CcSEcCtD
Triazolam—Insomnia—Timolol—coronary artery disease	0.000117	0.000511	CcSEcCtD
Triazolam—Dermatitis—Niacin—coronary artery disease	0.000117	0.000511	CcSEcCtD
Triazolam—Dizziness—Enalapril—coronary artery disease	0.000117	0.000511	CcSEcCtD
Triazolam—Pruritus—Perindopril—coronary artery disease	0.000117	0.000509	CcSEcCtD
Triazolam—Headache—Niacin—coronary artery disease	0.000117	0.000508	CcSEcCtD
Triazolam—Paraesthesia—Timolol—coronary artery disease	0.000116	0.000508	CcSEcCtD
Triazolam—Vomiting—Pravastatin—coronary artery disease	0.000116	0.000508	CcSEcCtD
Triazolam—Hyperhidrosis—Lisinopril—coronary artery disease	0.000116	0.000507	CcSEcCtD
Triazolam—Diarrhoea—Captopril—coronary artery disease	0.000116	0.000507	CcSEcCtD
Triazolam—Dyspnoea—Timolol—coronary artery disease	0.000116	0.000504	CcSEcCtD
Triazolam—Dizziness—Telmisartan—coronary artery disease	0.000116	0.000504	CcSEcCtD
Triazolam—Dermatitis—Pravastatin—coronary artery disease	0.000115	0.000503	CcSEcCtD
Triazolam—Decreased appetite—Ramipril—coronary artery disease	0.000115	0.000503	CcSEcCtD
Triazolam—Somnolence—Timolol—coronary artery disease	0.000115	0.000503	CcSEcCtD
Triazolam—Asthenia—Furosemide—coronary artery disease	0.000115	0.000502	CcSEcCtD
Triazolam—Headache—Pravastatin—coronary artery disease	0.000115	0.0005	CcSEcCtD
Triazolam—Anorexia—Lisinopril—coronary artery disease	0.000115	0.0005	CcSEcCtD
Triazolam—Fatigue—Ramipril—coronary artery disease	0.000114	0.000499	CcSEcCtD
Triazolam—Hypersensitivity—Losartan—coronary artery disease	0.000114	0.000497	CcSEcCtD
Triazolam—Nausea—Valsartan—coronary artery disease	0.000114	0.000495	CcSEcCtD
Triazolam—Pruritus—Furosemide—coronary artery disease	0.000113	0.000495	CcSEcCtD
Triazolam—Constipation—Ramipril—coronary artery disease	0.000113	0.000495	CcSEcCtD
Triazolam—Nausea—Olmesartan—coronary artery disease	0.000113	0.000493	CcSEcCtD
Triazolam—Vomiting—Trandolapril—coronary artery disease	0.000113	0.000493	CcSEcCtD
Triazolam—Diarrhoea—Perindopril—coronary artery disease	0.000113	0.000492	CcSEcCtD
Triazolam—Decreased appetite—Timolol—coronary artery disease	0.000113	0.000492	CcSEcCtD
Triazolam—Vomiting—Enalapril—coronary artery disease	0.000113	0.000491	CcSEcCtD
Triazolam—Dizziness—Captopril—coronary artery disease	0.000112	0.00049	CcSEcCtD
Triazolam—Dermatitis—Trandolapril—coronary artery disease	0.000112	0.000488	CcSEcCtD
Triazolam—Fatigue—Timolol—coronary artery disease	0.000112	0.000487	CcSEcCtD
Triazolam—Dermatitis—Enalapril—coronary artery disease	0.000112	0.000486	CcSEcCtD
Triazolam—Headache—Trandolapril—coronary artery disease	0.000111	0.000486	CcSEcCtD
Triazolam—Vomiting—Telmisartan—coronary artery disease	0.000111	0.000484	CcSEcCtD
Triazolam—Asthenia—Losartan—coronary artery disease	0.000111	0.000484	CcSEcCtD
Triazolam—Headache—Enalapril—coronary artery disease	0.000111	0.000484	CcSEcCtD
Triazolam—Pain—Timolol—coronary artery disease	0.000111	0.000484	CcSEcCtD
Triazolam—Nausea—Niacin—coronary artery disease	0.00011	0.000482	CcSEcCtD
Triazolam—Dermatitis—Telmisartan—coronary artery disease	0.00011	0.00048	CcSEcCtD
Triazolam—Diarrhoea—Furosemide—coronary artery disease	0.00011	0.000478	CcSEcCtD
Triazolam—Pruritus—Losartan—coronary artery disease	0.000109	0.000477	CcSEcCtD
Triazolam—Headache—Telmisartan—coronary artery disease	0.000109	0.000477	CcSEcCtD
Triazolam—Feeling abnormal—Ramipril—coronary artery disease	0.000109	0.000477	CcSEcCtD
Triazolam—Dizziness—Perindopril—coronary artery disease	0.000109	0.000476	CcSEcCtD
Triazolam—Insomnia—Lisinopril—coronary artery disease	0.000109	0.000474	CcSEcCtD
Triazolam—Nausea—Pravastatin—coronary artery disease	0.000109	0.000474	CcSEcCtD
Triazolam—Gastrointestinal pain—Ramipril—coronary artery disease	0.000108	0.000473	CcSEcCtD
Triazolam—Paraesthesia—Lisinopril—coronary artery disease	0.000108	0.000471	CcSEcCtD
Triazolam—Vomiting—Captopril—coronary artery disease	0.000108	0.000471	CcSEcCtD
Triazolam—Dyspnoea—Lisinopril—coronary artery disease	0.000107	0.000468	CcSEcCtD
Triazolam—Dermatitis—Captopril—coronary artery disease	0.000107	0.000467	CcSEcCtD
Triazolam—Somnolence—Lisinopril—coronary artery disease	0.000107	0.000466	CcSEcCtD
Triazolam—Feeling abnormal—Timolol—coronary artery disease	0.000107	0.000466	CcSEcCtD
Triazolam—Headache—Captopril—coronary artery disease	0.000106	0.000464	CcSEcCtD
Triazolam—Gastrointestinal pain—Timolol—coronary artery disease	0.000106	0.000462	CcSEcCtD
Triazolam—Dizziness—Furosemide—coronary artery disease	0.000106	0.000462	CcSEcCtD
Triazolam—Diarrhoea—Losartan—coronary artery disease	0.000106	0.000461	CcSEcCtD
Triazolam—Nausea—Trandolapril—coronary artery disease	0.000106	0.000461	CcSEcCtD
Triazolam—Nausea—Enalapril—coronary artery disease	0.000105	0.000459	CcSEcCtD
Triazolam—Vomiting—Perindopril—coronary artery disease	0.000105	0.000457	CcSEcCtD
Triazolam—Abdominal pain—Ramipril—coronary artery disease	0.000105	0.000457	CcSEcCtD
Triazolam—Decreased appetite—Lisinopril—coronary artery disease	0.000105	0.000456	CcSEcCtD
Triazolam—Dermatitis—Perindopril—coronary artery disease	0.000104	0.000453	CcSEcCtD
Triazolam—Nausea—Telmisartan—coronary artery disease	0.000104	0.000452	CcSEcCtD
Triazolam—Fatigue—Lisinopril—coronary artery disease	0.000104	0.000452	CcSEcCtD
Triazolam—Headache—Perindopril—coronary artery disease	0.000103	0.00045	CcSEcCtD
Triazolam—Pain—Lisinopril—coronary artery disease	0.000103	0.000449	CcSEcCtD
Triazolam—Constipation—Lisinopril—coronary artery disease	0.000103	0.000449	CcSEcCtD
Triazolam—Abdominal pain—Timolol—coronary artery disease	0.000103	0.000447	CcSEcCtD
Triazolam—Dizziness—Losartan—coronary artery disease	0.000102	0.000446	CcSEcCtD
Triazolam—Vomiting—Furosemide—coronary artery disease	0.000102	0.000444	CcSEcCtD
Triazolam—Dermatitis—Furosemide—coronary artery disease	0.000101	0.00044	CcSEcCtD
Triazolam—Nausea—Captopril—coronary artery disease	0.000101	0.00044	CcSEcCtD
Triazolam—Headache—Furosemide—coronary artery disease	0.0001	0.000438	CcSEcCtD
Triazolam—Feeling abnormal—Lisinopril—coronary artery disease	9.92e-05	0.000432	CcSEcCtD
Triazolam—Gastrointestinal pain—Lisinopril—coronary artery disease	9.84e-05	0.000429	CcSEcCtD
Triazolam—Vomiting—Losartan—coronary artery disease	9.84e-05	0.000429	CcSEcCtD
Triazolam—Nausea—Perindopril—coronary artery disease	9.8e-05	0.000427	CcSEcCtD
Triazolam—Hypersensitivity—Ramipril—coronary artery disease	9.77e-05	0.000426	CcSEcCtD
Triazolam—Dermatitis—Losartan—coronary artery disease	9.75e-05	0.000425	CcSEcCtD
Triazolam—Headache—Losartan—coronary artery disease	9.69e-05	0.000423	CcSEcCtD
Triazolam—Hypersensitivity—Timolol—coronary artery disease	9.56e-05	0.000417	CcSEcCtD
Triazolam—Nausea—Furosemide—coronary artery disease	9.53e-05	0.000415	CcSEcCtD
Triazolam—Asthenia—Ramipril—coronary artery disease	9.52e-05	0.000415	CcSEcCtD
Triazolam—Abdominal pain—Lisinopril—coronary artery disease	9.51e-05	0.000415	CcSEcCtD
Triazolam—Pruritus—Ramipril—coronary artery disease	9.39e-05	0.000409	CcSEcCtD
Triazolam—Asthenia—Timolol—coronary artery disease	9.31e-05	0.000406	CcSEcCtD
Triazolam—Clotiazepam—CYP2C19—coronary artery disease	9.3e-05	0.139	CrCbGaD
Triazolam—Nausea—Losartan—coronary artery disease	9.19e-05	0.000401	CcSEcCtD
Triazolam—Pruritus—Timolol—coronary artery disease	9.18e-05	0.0004	CcSEcCtD
Triazolam—Diarrhoea—Ramipril—coronary artery disease	9.08e-05	0.000396	CcSEcCtD
Triazolam—Diarrhoea—Timolol—coronary artery disease	8.87e-05	0.000387	CcSEcCtD
Triazolam—Hypersensitivity—Lisinopril—coronary artery disease	8.86e-05	0.000386	CcSEcCtD
Triazolam—Clobazam—CYP2C19—coronary artery disease	8.78e-05	0.131	CrCbGaD
Triazolam—Dizziness—Ramipril—coronary artery disease	8.77e-05	0.000382	CcSEcCtD
Triazolam—Asthenia—Lisinopril—coronary artery disease	8.63e-05	0.000376	CcSEcCtD
Triazolam—Dizziness—Timolol—coronary artery disease	8.58e-05	0.000374	CcSEcCtD
Triazolam—Quazepam—CYP2C19—coronary artery disease	8.51e-05	0.127	CrCbGaD
Triazolam—Pruritus—Lisinopril—coronary artery disease	8.51e-05	0.000371	CcSEcCtD
Triazolam—Vomiting—Ramipril—coronary artery disease	8.44e-05	0.000368	CcSEcCtD
Triazolam—Dermatitis—Ramipril—coronary artery disease	8.36e-05	0.000364	CcSEcCtD
Triazolam—Headache—Ramipril—coronary artery disease	8.31e-05	0.000362	CcSEcCtD
Triazolam—Vomiting—Timolol—coronary artery disease	8.25e-05	0.000359	CcSEcCtD
Triazolam—Diarrhoea—Lisinopril—coronary artery disease	8.23e-05	0.000359	CcSEcCtD
Triazolam—Dermatitis—Timolol—coronary artery disease	8.17e-05	0.000356	CcSEcCtD
Triazolam—Headache—Timolol—coronary artery disease	8.13e-05	0.000354	CcSEcCtD
Triazolam—Flunitrazepam—CYP2C19—coronary artery disease	8.04e-05	0.12	CrCbGaD
Triazolam—Dizziness—Lisinopril—coronary artery disease	7.96e-05	0.000347	CcSEcCtD
Triazolam—Nausea—Ramipril—coronary artery disease	7.88e-05	0.000344	CcSEcCtD
Triazolam—Nausea—Timolol—coronary artery disease	7.7e-05	0.000336	CcSEcCtD
Triazolam—Vomiting—Lisinopril—coronary artery disease	7.65e-05	0.000333	CcSEcCtD
Triazolam—Dermatitis—Lisinopril—coronary artery disease	7.58e-05	0.00033	CcSEcCtD
Triazolam—Headache—Lisinopril—coronary artery disease	7.54e-05	0.000329	CcSEcCtD
Triazolam—Adinazolam—CYP2C19—coronary artery disease	7.16e-05	0.107	CrCbGaD
Triazolam—Nausea—Lisinopril—coronary artery disease	7.15e-05	0.000312	CcSEcCtD
Triazolam—Temazepam—CYP2C19—coronary artery disease	6.17e-05	0.0919	CrCbGaD
Triazolam—Chlorprothixene—HTR2A—coronary artery disease	5.6e-05	0.0835	CrCbGaD
Triazolam—Clonazepam—ALB—coronary artery disease	5.55e-05	0.0828	CrCbGaD
Triazolam—Diazepam—CYP2C19—coronary artery disease	5.13e-05	0.0764	CrCbGaD
Triazolam—Diazepam—ALB—coronary artery disease	2.84e-05	0.0424	CrCbGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	6.41e-06	6.87e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALDOA—coronary artery disease	6.4e-06	6.86e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PGM1—coronary artery disease	6.4e-06	6.85e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTP1—coronary artery disease	6.37e-06	6.82e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	6.33e-06	6.78e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GPX2—coronary artery disease	6.33e-06	6.78e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOA2—coronary artery disease	6.33e-06	6.78e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPARGC1A—coronary artery disease	6.31e-06	6.75e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—HMOX1—coronary artery disease	6.28e-06	6.72e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SULT1A1—coronary artery disease	6.25e-06	6.69e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GPX4—coronary artery disease	6.25e-06	6.69e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCG5—coronary artery disease	6.25e-06	6.69e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HK1—coronary artery disease	6.25e-06	6.69e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	6.24e-06	6.69e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—DCN—coronary artery disease	6.21e-06	6.66e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CAT—coronary artery disease	6.19e-06	6.63e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CKB—coronary artery disease	6.18e-06	6.62e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PYGB—coronary artery disease	6.18e-06	6.62e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HADHA—coronary artery disease	6.17e-06	6.61e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PSMA6—coronary artery disease	6.13e-06	6.57e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PSMB5—coronary artery disease	6.13e-06	6.57e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTA1—coronary artery disease	6.1e-06	6.54e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALDH2—coronary artery disease	6.04e-06	6.47e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LPA—coronary artery disease	6.03e-06	6.46e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APOB—coronary artery disease	6.01e-06	6.44e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CTGF—coronary artery disease	5.99e-06	6.41e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HMGCR—coronary artery disease	5.93e-06	6.36e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GOT2—coronary artery disease	5.93e-06	6.36e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	5.89e-06	6.31e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—LIPC—coronary artery disease	5.89e-06	6.31e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HBA1—coronary artery disease	5.89e-06	6.31e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2C19—coronary artery disease	5.89e-06	6.31e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3C2A—coronary artery disease	5.89e-06	6.31e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOC3—coronary artery disease	5.85e-06	6.27e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTM1—coronary artery disease	5.85e-06	6.27e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PLCB3—coronary artery disease	5.84e-06	6.26e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—LDLR—coronary artery disease	5.82e-06	6.23e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	5.81e-06	6.23e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—COX5B—coronary artery disease	5.81e-06	6.22e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PFKFB3—coronary artery disease	5.81e-06	6.22e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLIN1—coronary artery disease	5.81e-06	6.22e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—DLAT—coronary artery disease	5.81e-06	6.22e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTM2—coronary artery disease	5.81e-06	6.22e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOA5—coronary artery disease	5.79e-06	6.2e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTT1—coronary artery disease	5.75e-06	6.16e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC9A1—coronary artery disease	5.75e-06	6.16e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—LPL—coronary artery disease	5.74e-06	6.15e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CETP—coronary artery disease	5.68e-06	6.09e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GCLC—coronary artery disease	5.68e-06	6.09e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—P4HB—coronary artery disease	5.67e-06	6.08e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	5.62e-06	6.02e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SDC1—coronary artery disease	5.62e-06	6.02e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GPX1—coronary artery disease	5.6e-06	6e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	5.57e-06	5.97e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	5.51e-06	5.9e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SULT1E1—coronary artery disease	5.51e-06	5.9e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PLCB1—coronary artery disease	5.46e-06	5.84e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CD36—coronary artery disease	5.46e-06	5.84e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	5.44e-06	5.83e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPP2CA—coronary artery disease	5.39e-06	5.77e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PSMA6—coronary artery disease	5.31e-06	5.69e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PSMB5—coronary artery disease	5.31e-06	5.69e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.3e-06	5.68e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ABCA1—coronary artery disease	5.29e-06	5.67e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AKR1B1—coronary artery disease	5.25e-06	5.63e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HK2—coronary artery disease	5.25e-06	5.63e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—VCAN—coronary artery disease	5.25e-06	5.62e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALDOA—coronary artery disease	5.21e-06	5.58e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CTGF—coronary artery disease	5.19e-06	5.56e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MTHFR—coronary artery disease	5.17e-06	5.54e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HMGCR—coronary artery disease	5.14e-06	5.51e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GOT2—coronary artery disease	5.14e-06	5.51e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GGT1—coronary artery disease	5.12e-06	5.49e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GOT1—coronary artery disease	5.12e-06	5.49e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—DCN—coronary artery disease	5.06e-06	5.42e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC27A1—coronary artery disease	5.04e-06	5.39e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LCAT—coronary artery disease	4.94e-06	5.29e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CPT1B—coronary artery disease	4.94e-06	5.29e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALDH2—coronary artery disease	4.92e-06	5.27e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—AGT—coronary artery disease	4.91e-06	5.26e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOA4—coronary artery disease	4.85e-06	5.19e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APOE—coronary artery disease	4.81e-06	5.15e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	4.8e-06	5.14e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LIPC—coronary artery disease	4.79e-06	5.14e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HBA1—coronary artery disease	4.79e-06	5.14e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2C19—coronary artery disease	4.79e-06	5.14e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	4.79e-06	5.14e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOC3—coronary artery disease	4.76e-06	5.1e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APOA1—coronary artery disease	4.76e-06	5.1e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LDLR—coronary artery disease	4.74e-06	5.07e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	4.73e-06	5.07e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PLCB1—coronary artery disease	4.73e-06	5.06e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GCLM—coronary artery disease	4.68e-06	5.01e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PDHA1—coronary artery disease	4.68e-06	5.01e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC9A1—coronary artery disease	4.68e-06	5.01e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTT1—coronary artery disease	4.68e-06	5.01e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.64e-06	4.97e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CETP—coronary artery disease	4.63e-06	4.95e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GCLC—coronary artery disease	4.63e-06	4.95e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTP1—coronary artery disease	4.6e-06	4.93e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCA1—coronary artery disease	4.58e-06	4.91e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SDC1—coronary artery disease	4.57e-06	4.9e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	4.56e-06	4.88e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HMOX1—coronary artery disease	4.54e-06	4.86e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.53e-06	4.86e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.53e-06	4.86e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CAT—coronary artery disease	4.48e-06	4.8e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC22A3—coronary artery disease	4.47e-06	4.78e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GOT1—coronary artery disease	4.44e-06	4.75e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GGT1—coronary artery disease	4.44e-06	4.75e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ARNTL—coronary artery disease	4.4e-06	4.71e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HADH—coronary artery disease	4.4e-06	4.71e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOB—coronary artery disease	4.35e-06	4.66e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PSMA6—coronary artery disease	4.32e-06	4.63e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PSMB5—coronary artery disease	4.32e-06	4.63e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	4.31e-06	4.62e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTM1—coronary artery disease	4.23e-06	4.53e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CTGF—coronary artery disease	4.22e-06	4.52e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPARG—coronary artery disease	4.19e-06	4.49e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HMGCR—coronary artery disease	4.18e-06	4.48e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GOT2—coronary artery disease	4.18e-06	4.48e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOA2—coronary artery disease	4.17e-06	4.47e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	4.17e-06	4.47e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GPX2—coronary artery disease	4.17e-06	4.47e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—LPL—coronary artery disease	4.15e-06	4.45e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—POMC—coronary artery disease	4.13e-06	4.43e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCG5—coronary artery disease	4.12e-06	4.41e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SULT1A1—coronary artery disease	4.12e-06	4.41e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HK1—coronary artery disease	4.12e-06	4.41e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GPX4—coronary artery disease	4.12e-06	4.41e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HADHA—coronary artery disease	4.07e-06	4.36e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GPX1—coronary artery disease	4.05e-06	4.34e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA1—coronary artery disease	4.03e-06	4.31e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTP1—coronary artery disease	3.99e-06	4.27e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LPA—coronary artery disease	3.98e-06	4.26e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	3.95e-06	4.23e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CD36—coronary artery disease	3.94e-06	4.22e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HMOX1—coronary artery disease	3.93e-06	4.21e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPP2CA—coronary artery disease	3.89e-06	4.17e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CAT—coronary artery disease	3.88e-06	4.15e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.85e-06	4.13e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PLCB1—coronary artery disease	3.85e-06	4.12e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOA5—coronary artery disease	3.82e-06	4.09e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.77e-06	4.04e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALB—coronary artery disease	3.77e-06	4.04e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOB—coronary artery disease	3.76e-06	4.03e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—P4HB—coronary artery disease	3.74e-06	4.01e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MTHFR—coronary artery disease	3.74e-06	4e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCA1—coronary artery disease	3.73e-06	3.99e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.67e-06	3.93e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTM1—coronary artery disease	3.66e-06	3.92e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GOT1—coronary artery disease	3.61e-06	3.87e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GGT1—coronary artery disease	3.61e-06	3.87e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NOS3—coronary artery disease	3.61e-06	3.86e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—LPL—coronary artery disease	3.59e-06	3.85e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—AGT—coronary artery disease	3.55e-06	3.8e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GPX1—coronary artery disease	3.51e-06	3.76e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOE—coronary artery disease	3.48e-06	3.73e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—VCAN—coronary artery disease	3.46e-06	3.71e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOA1—coronary artery disease	3.44e-06	3.68e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.44e-06	3.68e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CD36—coronary artery disease	3.42e-06	3.66e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPP2CA—coronary artery disease	3.37e-06	3.61e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—DCN—coronary artery disease	3.34e-06	3.57e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS2—coronary artery disease	3.3e-06	3.53e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.24e-06	3.48e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTP1—coronary artery disease	3.24e-06	3.47e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MTHFR—coronary artery disease	3.24e-06	3.47e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	3.21e-06	3.44e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HMOX1—coronary artery disease	3.2e-06	3.43e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HBA1—coronary artery disease	3.16e-06	3.39e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.16e-06	3.39e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.16e-06	3.39e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LIPC—coronary artery disease	3.16e-06	3.39e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CAT—coronary artery disease	3.16e-06	3.38e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOC3—coronary artery disease	3.14e-06	3.37e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LDLR—coronary artery disease	3.12e-06	3.35e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.09e-06	3.31e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.09e-06	3.31e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AGT—coronary artery disease	3.08e-06	3.29e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOB—coronary artery disease	3.06e-06	3.28e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GCLC—coronary artery disease	3.05e-06	3.27e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CETP—coronary artery disease	3.05e-06	3.27e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPARG—coronary artery disease	3.03e-06	3.25e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SDC1—coronary artery disease	3.02e-06	3.23e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOE—coronary artery disease	3.01e-06	3.23e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—POMC—coronary artery disease	2.99e-06	3.2e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.98e-06	3.19e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOA1—coronary artery disease	2.98e-06	3.19e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LPL—coronary artery disease	2.93e-06	3.13e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GPX1—coronary artery disease	2.85e-06	3.06e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.85e-06	3.06e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.85e-06	3.05e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.85e-06	3.05e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CTGF—coronary artery disease	2.78e-06	2.98e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CD36—coronary artery disease	2.78e-06	2.98e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GOT2—coronary artery disease	2.76e-06	2.95e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.76e-06	2.95e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPP2CA—coronary artery disease	2.75e-06	2.94e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALB—coronary artery disease	2.72e-06	2.92e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MTHFR—coronary artery disease	2.63e-06	2.82e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPARG—coronary artery disease	2.62e-06	2.81e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NOS3—coronary artery disease	2.61e-06	2.79e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—POMC—coronary artery disease	2.59e-06	2.77e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.54e-06	2.72e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AGT—coronary artery disease	2.5e-06	2.68e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.46e-06	2.63e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOE—coronary artery disease	2.45e-06	2.63e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOA1—coronary artery disease	2.42e-06	2.6e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS2—coronary artery disease	2.38e-06	2.55e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GOT1—coronary artery disease	2.38e-06	2.55e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GGT1—coronary artery disease	2.38e-06	2.55e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALB—coronary artery disease	2.36e-06	2.53e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.32e-06	2.49e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NOS3—coronary artery disease	2.26e-06	2.42e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.14e-06	2.29e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPARG—coronary artery disease	2.14e-06	2.29e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.12e-06	2.27e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.11e-06	2.26e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—POMC—coronary artery disease	2.11e-06	2.26e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CAT—coronary artery disease	2.08e-06	2.23e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS2—coronary artery disease	2.06e-06	2.21e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CA—coronary artery disease	2.03e-06	2.17e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOB—coronary artery disease	2.02e-06	2.16e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.97e-06	2.11e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LPL—coronary artery disease	1.93e-06	2.07e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALB—coronary artery disease	1.92e-06	2.06e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GPX1—coronary artery disease	1.88e-06	2.02e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NOS3—coronary artery disease	1.84e-06	1.97e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CD36—coronary artery disease	1.83e-06	1.96e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.81e-06	1.94e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.74e-06	1.86e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.68e-06	1.8e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—AKT1—coronary artery disease	1.66e-06	1.78e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AGT—coronary artery disease	1.65e-06	1.77e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOE—coronary artery disease	1.62e-06	1.73e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOA1—coronary artery disease	1.6e-06	1.71e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1.47e-06	1.57e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPARG—coronary artery disease	1.41e-06	1.51e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—POMC—coronary artery disease	1.39e-06	1.49e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CA—coronary artery disease	1.27e-06	1.36e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALB—coronary artery disease	1.27e-06	1.36e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NOS3—coronary artery disease	1.21e-06	1.3e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—AKT1—coronary artery disease	1.2e-06	1.28e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.11e-06	1.19e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AKT1—coronary artery disease	1.04e-06	1.11e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.03e-06	1.11e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AKT1—coronary artery disease	8.45e-07	9.05e-06	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CA—coronary artery disease	6.82e-07	7.3e-06	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AKT1—coronary artery disease	5.57e-07	5.97e-06	CbGpPWpGaD
